Riyadh Biocentral will host over 200 biotech companies driving advancements in genomics, biomanufacturing, and sustainable healthcare. Supported by biotech-focused funds and venture capital investment, these companies will thrive in a hub designed for innovation. The Strategy aims to establish Riyadh as the region’s leading biotechnology and biopharmaceutical powerhouse, fostering growth and scientific breakthroughs.